Literature DB >> 20827555

Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature.

Muhanned Abu-Hijleh1, Samuel Evans, Bassam Aswad.   

Abstract

Inflammatory bowel disease (IBD) can affect the lung parenchyma and airways. Rarely it involves the pleural space and pericardium, causing inflammatory exudative pleural and/or pericardial effusions. In this report, we describe a 76-year-old patient with recurrent sterile exudative pleuropericarditis that gradually responded to treatment with steroids, and we review the relevant literature. Thoracic serositis in patients with IBD can cause pleuritis, pericarditis, pleuropericarditis, or myopericarditis. This is a relatively rare presentation of the uncommon and probably underreported and underrecognized pulmonary extraintestinal manifestations of IBD. Pleuropericardial inflammatory disease and effusion can be directly related to IBD, its complications, associated infections, or the medications used to treat it. Serositis directly related to IBD is a diagnosis of exclusion. It is important to evaluate the pleural effusion and rule out other etiologies before making this diagnosis. Pleural or pericardial biopsies are rarely necessary, and probably show nonspecific acute and chronic inflammatory changes. Although the specific pathophysiology of pleuropericardial disease in patients with IBD remains unclear, the response to systemic steroids is usually adequate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827555     DOI: 10.1007/s00408-010-9259-y

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

1.  Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease.

Authors:  M Faller; B Gasser; G Massard; G Pauli; E Quoix
Journal:  Respiration       Date:  2000       Impact factor: 3.580

Review 2.  Sulphasalazine and lung toxicity.

Authors:  S D Parry; C Barbatzas; E T Peel; J R Barton
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

Review 3.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Ian Storch; David Sachar; Seymour Katz
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

4.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis.

Authors:  S Orii; T Chiba; I Nakadate; T Fujiwara; N Ito; M Ishii; S Oana; T Chida; N Kudara; T Terui; T Yamaguchi; K Suzuki
Journal:  J Clin Gastroenterol       Date:  2001-03       Impact factor: 3.062

6.  Sarcoid-like lymphocytosis of the lower respiratory tract in patients with active Crohn's disease.

Authors:  J M Smiéjan; J Cosnes; S Chollet-Martin; P Soler; F M Basset; Y Le Quintrec; A J Hance
Journal:  Ann Intern Med       Date:  1986-01       Impact factor: 25.391

7.  Evidence of lymphocyte alveolitis in Crohn's disease.

Authors:  B Wallaert; J F Colombel; A B Tonnel; P Bonniere; A Cortot; J C Paris; C Voisin
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

8.  Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.

Authors:  G Haralambou; A S Teirstein; J Gil; D H Present
Journal:  Mt Sinai J Med       Date:  2001-11

9.  Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis.

Authors:  C R Swinburn; G J Jackson; I Cobden; T Ashcroft; G N Morritt; P A Corris
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

10.  Increased pulmonary and intestinal permeability in Crohn's disease.

Authors:  A Adenis; J F Colombel; P Lecouffe; B Wallaert; B Hecquet; X Marchandise; A Cortot
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

View more
  9 in total

Review 1.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Chronic GvHD-associated serositis and pericarditis.

Authors:  J T Leonard; L F Newell; G Meyers; B Hayes-Lattin; J Gajewski; S Heitner; S Nonas; B Allen; A Stentz; R Frires; R T Maziarz; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

4.  Pericarditis: pathophysiology, diagnosis, and management.

Authors:  Massimo Imazio
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 5.  5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.

Authors:  Glen Brown
Journal:  Can J Hosp Pharm       Date:  2016-12-23

6.  An Unusual Case of Hemorrhagic Pleuropericarditis After COVID-19 Vaccination.

Authors:  Aneeqa Javed; Yelizaveta Medina; Julia Tian; Muhammad Junaid Alvi; Syeda Sahra; Geurys Rojas-Marte
Journal:  Cureus       Date:  2022-05-08

Review 7.  Cardiovascular Manifestations in Inflammatory Bowel Disease: A Systematic Review of the Pathogenesis and Management of Pericarditis.

Authors:  Ravi S Patel; Sai Rohit Reddy; Adiona Llukmani; Ayat Hashim; Dana R Haddad; Dutt S Patel; Farrukh Ahmad; Domonick K Gordon
Journal:  Cureus       Date:  2021-03-20

8.  A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab.

Authors:  Hakan Ozkan; Ahmet Seckin Cetinkaya; Tekin Yildiz; Tahsin Bozat
Journal:  Case Rep Rheumatol       Date:  2013-07-18

Review 9.  Inflammation of the Pleural Cavity: A Review on Pathogenesis, Diagnosis and Implications in Tumor Pathophysiology.

Authors:  Georgia Karpathiou; Michel Péoc'h; Anand Sundaralingam; Najib Rahman; Marios E Froudarakis
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.